Back

HELIOS-B: latest data - and what this means for patient outcomes

9 May 2026 (14:43 - 14:53)
Organised by: Logo
Congress Presentation Part of: Targeting ATTR-CM at the source: how vutrisiran is improving outcomes for patients Cardiac Amyloidosis Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Antoine Bondue

Free University of Brussels (ULB), Brussels (Belgium)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES)
Presentation thumbnail
The importance of TTR rapid knockdown in ATTR-CM
Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES)
Presentation thumbnail
Vutrisiran in ATTR-CM: Experience from clinical practice
Associate Professor R. Pfister (Cologne, DE)
Presentation thumbnail
Panel discussion, audience questions and closing remarks
Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES) Professor A. Bondue (Brussels, BE) Associate Professor R. Pfister (Cologne, DE)

Access the full session

Session thumbnail
Targeting ATTR-CM at the source: how vutrisiran is improving outcomes for patients

The Event

Event poster

Heart Failure 2026

9 May 2026 14:43 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources